Literature DB >> 12240710

Mechanisms of obesity-associated cardiovascular and renal disease.

John E Hall1, Errol D Crook, Daniel W Jones, Marion R Wofford, Patricia M Dubbert.   

Abstract

Obesity is the most common nutritional disorder in the United States. Growing evidence suggests that obesity initiates a cascade of disorders including hypertension, diabetes, atherosclerosis, and chronic renal disease, many of which are interdependent. Abnormal kidney function, caused by increased renal tubular reabsorption, initiates volume expansion and increased blood pressure during excess weight gain, and the hypertension and metabolic abnormalities associated with obesity, in turn, contribute to chronic renal disease. Obesity causes cardiac and vascular disease through well-known mediators such as hypertension, type II diabetes, and dyslipidemia, but there is evidence for less well-characterized mediators such as chronic inflammation and hypercoagulation. Although obesity is increasingly recognized as a serious health problem, there are still many unanswered questions about how the multiple disorders associated with excess weight gain interact to cause cardiovascular and renal disease. Also, there are few studies that have examined whether sustained weight loss in obese subjects can reverse these changes. In view of the "epidemic" of obesity in our country and the excess burden of cardiovascular and renal disease in minority populations, addressing these issues is of paramount importance for the Jackson Heart Study, as well as for other national health initiatives.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12240710     DOI: 10.1097/00000441-200209000-00003

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  108 in total

Review 1.  The Role of Sympatho-Inhibition in Combination Treatment of Obesity-Related Hypertension.

Authors:  Revathy Carnagarin; Cynthia Gregory; Omar Azzam; Graham S Hillis; Carl Schultz; Gerald F Watts; Damon Bell; Vance Matthews; Markus P Schlaich
Journal:  Curr Hypertens Rep       Date:  2017-10-28       Impact factor: 5.369

Review 2.  Impact of obesity as an independent risk factor for the development of renal injury: implications from rat models of obesity.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Brianca Fizer; Alyssa Pennington; Ashley Szabo-Johnson; Willie L Thompson; Denise C Cornelius; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2018-12-12

Review 3.  The impacts of obesity on the cardiovascular and renal systems: cascade of events and therapeutic approaches.

Authors:  Zohreh Soltani; Vaughn Washco; Stephen Morse; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-02       Impact factor: 5.369

4.  Altered renal hemodynamics is associated with glomerular lipid accumulation in obese Dahl salt-sensitive leptin receptor mutant rats.

Authors:  Kasi C McPherson; Corbin A Shields; Bibek Poudel; Ashley C Johnson; Lateia Taylor; Cassandra Stubbs; Alyssa Nichols; Denise C Cornelius; Michael R Garrett; Jan M Williams
Journal:  Am J Physiol Renal Physiol       Date:  2020-02-18

Review 5.  Impaired cardiac function in leptin-deficient mice.

Authors:  Jun Ren; Heng Ma
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

6.  Impact of obesity on renal structure and function in the presence and absence of hypertension: evidence from melanocortin-4 receptor-deficient mice.

Authors:  Jussara M do Carmo; Lakshmi S Tallam; John V Roberts; Elizabeth L Brandon; John Biglane; Alexandre A da Silva; John E Hall
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-07-15       Impact factor: 3.619

Review 7.  The role of the sympathetic nervous system in obesity-related hypertension.

Authors:  Alexandre A da Silva; Jussara do Carmo; John Dubinion; John E Hall
Journal:  Curr Hypertens Rep       Date:  2009-06       Impact factor: 5.369

8.  Decreased renal function in overweight and obese prepubertal children.

Authors:  Liane Correia-Costa; Alberto Caldas Afonso; Franz Schaefer; João Tiago Guimarães; Manuela Bustorff; António Guerra; Henrique Barros; Ana Azevedo
Journal:  Pediatr Res       Date:  2015-07-07       Impact factor: 3.756

9.  Blood pressure control and components of the metabolic syndrome: the GOOD survey.

Authors:  Walter Zidek; Lisa Naditch-Brûlé; Stefano Perlini; Csaba Farsang; Sverre E Kjeldsen
Journal:  Cardiovasc Diabetol       Date:  2009-09-15       Impact factor: 9.951

10.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.